DK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Delek US Holdings is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The stock has improved on recent earnings and operational execution, but the current setup is better suited to an already-oriented refiner recovery trade than a fresh long-term entry. My direct view: hold off on buying today and wait for a better risk/reward setup. The recent technical strength is real, but analyst views remain mixed, options positioning is bearish overall, and the upside from here looks more limited than the downside if refining sentiment weakens.
Technically, DK is in a short-term bullish structure: SMA_5 is above SMA_20 and SMA_200, which confirms an upward trend, and MACD remains positive at 0.501. However, the MACD histogram is contracting, which suggests momentum is cooling rather than expanding. RSI_6 at 49.631 is neutral, so the stock is not oversold or strongly trending. Price at 45 is only slightly above the pivot at 44.637, with resistance at 48.411 (R1) and 50.743 (R2). That means upside exists, but the stock is already near a fair technical mid-zone rather than an obvious bargain entry.
["Q1 2026 sales of $2.65B beat expectations of $2.42B.", "Enterprise Optimization Plan is driving higher yields and management projects $220M in annual cash flow improvement.", "Recent stock reaction has been strong, with shares up 17.5% since last Friday after the earnings report.", "Analysts acknowledge a positive outlook if the optimization plan keeps delivering.", "Technical trend remains constructive with bullish moving averages and positive MACD."]
["Q1 2026 revenue was only up 0.42% YoY, so top-line growth is very modest.", "Net income remains negative at -$201.3M and EPS is still deeply negative at -$3.34.", "Gross margin is still negative at -5.08%, showing profitability remains weak.", "Options positioning is bearish with a 2.54 put-call open interest ratio.", "Analyst ratings are mixed, with several Hold/Equal Weight/Neutral views despite some upgrades.", "No meaningful insider, hedge fund, or congress trading support is visible."]
In Q1 2026, Delek reported revenue of $2.653B, which beat estimates and was up 0.42% YoY. That is a positive surprise, but the broader financial picture is still weak: net income was -$201.3M, EPS was -$3.34, and gross margin remained negative at -5.08%. The improvement in net income and EPS versus last year is encouraging, but the company is not yet showing clean profitability. The latest quarter season is Q1 2026.
Analyst sentiment is mixed but slightly improving. Goldman Sachs upgraded DK to Buy with a $55 target, and Raymond James and Mizuho are also constructive. On the other hand, TD Cowen cut its target to $44 and kept Hold, Morgan Stanley is at Equal Weight with a $41 target, Citi is Neutral at $44, UBS is Neutral at $48, and BofA remains Underperform despite lifting its target to $40. The pros view is that cost cuts, SRE benefits, better marketing/wholesale strategy, and logistics growth can lift free cash flow. The cons view is that refining margins may not normalize quickly, and the market is still skeptical about the durability of earnings improvement.
